Delivery Order SPE2DB25D7067-SPE2DB25FSVSD
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order valued at $10,447.93 from the Defense Logistics Agency's Medical Supply Chain on August 11, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,158.40 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $38,784.40 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which has an ultimate completion date of August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,981.40 firm-fixed price delivery order is for the supply of Fluorescein Sodium 10% Vial, 5 mL, a pharmaceutical product used in various medical applications. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,586.58 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed price contract, designated as a child order under a larger indefinite delivery contract vehicle, carries a completion date of August 12, 2025, and represents a competitive award with no set-aside designation. The contract reflects the company's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $1,173.52 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025. This firm fixed-price delivery order, which represents a child award under a larger contract vehicle, carries an ultimate completion date of August 13, 2025. The contract was competitively awarded with no set-aside designation and utilizes...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $49,806.00 from the Defense Logistics Agency's Medical Supply Chain on August 4, 2025. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is set to be completed by August 5, 2025. The award carries no set-aside designation and reflects AmerisourceBergen's established role as a critical pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,006.19 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. This competitively awarded, firm fixed-price delivery order (4569124238) carries an ultimate completion date of September 15, 2025, and represents a child contract issued under a larger contract vehicle. The award involves the supply of pharmaceutical products and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $85,972.33 by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,726.24 by the Defense Logistics Agency's Medical Supply Chain on August 25, 2025. This competitively awarded, firm fixed-price contract with an ultimate completion date of August 26, 2025 represents a child order under the company's larger indefinite delivery contract vehicle. The award carries no set-aside designation and falls under the...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVSDDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for Fluorescein Sodium 10% Vial 5ML with a ceiling value of $8,513.88. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is set for ultimate completion by August 28, 2025. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government, specifically supporting military and veteran healthcare systems through the DLA's medical supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to support military healthcare programs globally. The Defense Logistics Agency's pharmaceutical procurement strategy includes plans for the Pharmaceutical Prime Vendor Global Program Generation V, which envisions multiple awards across separate regions to ensure robust supply chain resilience for Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 8/27/25 |